Form 4 for CRL Charles River Laboratories
Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-23 · accession 0001127602-22-006657 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-24 | 2022-02-23 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $292.75 | -395 | 19.9K | -2% | -$115.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-23 | S | D | 395 | $292.75 | 19,852 | D | — | — |